Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: J Mol Med (Berl). 2016 Sep 27;94(10):1111–1127. doi: 10.1007/s00109-016-1465-5

Table 1.

CANDLE/PRAAS and SAVI demographics

Demographics PRAAS/CANDLE
(n = 37)
SAVIb(n = 14)
Age of onseta Infancy–6 months Infancy–6 months
Gender 13 F/24 M 5 F/9 M
Ethnicity
   Hispanic 15 1
   Japanese 10 0
   Caucasian 7 3
   Afro-Jamaican 2 0
   Palestinian 1 0
   Ashkenazi Jewish 1 0
   French-Canadian 0 5
   Turkish 0 2
   Ukrainian 0 1
   Mixed Ethnicity 1 1
   Unknown 0 1
Clinical outcome at last published assessment
   Alive 26 (70.3 %) 10 (71.4 %)
   Deceased 11 (29.7 %) 4 (28.6 %)
    Respiratory failure (6, 54, and 63 years old)/(14, 15, and 16 years oldc) 3 3
    Congestive heart failure (47 years old) 1 0
    Presumed progression of chronic liver and kidney disease (25 years old) 1 0
    Sepsis, recurrent pancreatitis (10 years old) 1 0
    Presumed sepsis (8 years old) 1 0
    Necrotizing fasciitis (29 years old) 0 1
    Unknown (4, 6, 14, and 26 years old) 4 0

References. PRAAS/CANDLE: 3, 13–23, includes 7 previously unpublished patients evaluated or reviewed at NIH (3 with limited information not included in Table 2). SAVI: 4, 26–29, includes 1 previously unpublished patient evaluated at NIH

a

PRAAS/CANDLE: seven with later onset (between 11 months–4 years). SAVI: three within one family with later onset, two as teenagers, one as adult

b

Four cases within one family

c

Respiratory failure in SAVI likely related to underlying SAVI-related lung disease. Secondary infection was noted in two (14 and 15 year old)